- Home
- IOBT vs MDCX Comparison
IOBT vs MDCX Comparison
Compare IOBT & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.69
Company Overview
Basic Information| Metric | IOBT | MDCX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2M | 53.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | IOBT | MDCX |
|---|---|---|
| Price | $0.69 | $1.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $3.50 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 843.3K | 357.4K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $1.68 |
| 52 Week High | $2.79 | $8.94 |
Technical Indicators
Market Signals| Indicator | IOBT | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 41.11 |
| Support Level | $0.66 | $1.68 |
| Resistance Level | $0.88 | $2.03 |
| Average True Range (ATR) | 0.08 | 0.20 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 35.14 | 27.11 |
Price Performance
Historical Comparison IOBT
MDCX
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.